AirwayLab

AirwayLab

Free flow limitation analysis for CPAP and BiPAP data

D
@demianvoorhagen
Published on Sep 15, 2026
Visit site
11 PeerPush
🔥
Awarded
Trending Now
PeerPush

Details

Target Audience
Hobbyists
Pricing
Freemium from $9

Discovery signals

How AI and people discover AirwayLab on PeerPush

AI-readyAI-readyWhether this product carries the structured data - use cases, audiences, platforms - that lets AI match it to the right questions.
Structured

Described for AI to match

Described for AI with use cases, audiences, platforms and pricing so assistants can match it to the right questions.
Discoverable nowDiscoverable nowWhether this product is queryable through the PeerPush API and MCP right now.
Live

Via the PeerPush API and MCP

Queryable through the PeerPush API, MCP and semantic search from day one.

About AirwayLab

AirwayLab is a free, browser-based tool that analyzes CPAP and BiPAP SD card data. The supported-machine list lives at airwaylab.app and grows as new parsers ship. It runs research-grade engines (Glasgow Index, WAT, NED, and an oximetry pipeline) to score flow limitation, breathing-pattern instability, and oxygen levels beyond the standard AHI number your machine reports. All core analysis runs client-side in Web Workers. Your data stays on your device unless you opt in to cloud backup, AI insights, or research contribution. The analysis engine is open source (GPL-3.0) and publicly auditable on GitHub. The free tier runs the full analysis with limits on history and AI insights. Paid tiers add unlimited AI analysis, longer history, and PDF export. Current tiers and prices are on airwaylab.app. AirwayLab is not a medical device. It is not FDA or CE cleared. All analysis is for informational and educational purposes only. Always discuss results with your sleep physician before making therapy changes.

Product Video

Watch a video demo of AirwayLab.

Screenshots

Screenshot 1 of AirwayLab
Screenshot 2 of AirwayLab

Reviews (1)

Average 5.0 out of 5

5.0

Based on 1 review

5
1
4
0
3
0
2
0
1
0

Comments (0)

No comments yet. Be the first to share your thoughts!